Skye Bioscience Inc (NAS:SKYE)
$ 5.35 -0.09 (-1.65%) Market Cap: 162.31 Mil Enterprise Value: 95.69 Mil PE Ratio: 0 PB Ratio: 2.07 GF Score: 40/100

Skye Bioscience Inc at HC Wainwright Ophthalmology Virtual Conference Transcript

Aug 16, 2023 / 11:00AM GMT
Release Date Price: $3.78 (-4.43%)
Kyle Meury
H.C. Wainwright & Co., LLC - Analyst

Good morning, everyone, and thank you for joining the H.C. Wainwright Third Annual Virtual Ophthalmology Conference. My name is Kyle Meury, and I'm an analyst from the corporate access team.

H.C. Wainwright is a full-service investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private companies across multiple sectors and regions. We have a total of 24 publishing senior analysts and over 640 companies covered across all sectors. Please visit hcwco.com for more information.

(Conference Instructions) With that said, have a productive and enjoyable day. And I'd like to introduce our presenter, Tu Diep, Chief Development Officer, from Skye Bioscience. Thank you.

Tu Diep
Skye Bioscience, Inc. - Chief Development Officer

Thanks. Thanks, Kyle. Appreciate everybody coming to listen to this presentation, and thanks to H.C. Wainwright for putting this on and giving us the opportunity to present. So before I start, I want to make sure

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot